Partnerships
We collaborate with partners who bring complementary expertise to expand what’s possible for patients with autoimmune disease.
Building the future of Treg cell therapy.
We’re interested in partnering with organizations who share our commitment to advancing regulatory T cell (Treg) therapy for autoimmune and inflammatory disease. If you’d like to discuss a potential collaboration, contact us.
Sonoma Biotherapeutics is collaborating with Regeneron to advance a pipeline of Treg cell therapies for autoimmune diseases.